Vericel Corporation (VCEL) is a publicly traded Healthcare sector company. As of May 21, 2026, VCEL trades at $35.55 with a market cap of $1.78B and a P/E ratio of 106.46. VCEL moved +2.65% today. Year to date, VCEL is -4.53%; over the trailing twelve months it is -18.66%. Its 52-week range spans $28.95 to $63.00. Analyst consensus is strong buy with an average price target of $61.25. Rallies surfaces VCEL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes VCEL SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $35.55 |
| Market Cap | $1.78B |
| P/E Ratio | 106.46 |
| EPS | $0.33 |
| Dividend Yield | 0.00% |
| 52-Week High | $63.00 |
| 52-Week Low | $28.95 |
| Volume | 83 |
| Avg Volume | 0 |
| Revenue (TTM) | $276.26M |
| Net Income | $16.52M |
| Gross Margin | 74.42% |
6 analysts cover VCEL: 0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $61.25.